Effectiveness and safety of immune checkpoint inhibitors in Black patients versus White patients in a US national health system: a retrospective cohort study. - Miller S; Jiang R; Schipper M; Fritsche LG; Strohbehn G; Wallace B; Brinzevich D; Falvello V; McMahon BH; Zamora-Resendiz R; Ramnath N; Dai X; et al. (The Lancet. Oncology, 2024)